Viatris asks US court to clear Wegovy generic from Novo patent claims
Mylan Pharmaceuticals, part of Viatris, filed in Delaware federal court seeking a ruling that its proposed Wegovy generic would not infringe Novo Nordisk's patent rights.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Mylan asks US court to clear Wegovy generic from Novo patent claims
By Blake BrittainGeneric drugmaker Viatris NASDAQ:VTRS has sued Danish pharmaceutical giant Novo Nordisk OMXCOP:NOVO_B in Delaware federal court, seeking a ruling that its proposed generic of Novo's blockbuster GLP-1 drug Wegovy would not violate Novo's patent rights.The case is Mylan Pharmaceutica…